RORC and cancer: In addition, CR, as well as reduced levels of IGF-1, can decrease genomic instability via Ras- or phosphatidylinositol-3 kinase (PI3K)/Akt/Tor/S6K-dependent mechanisms, which contribute to reducing cancer incidence [89,90] in agreement with what was shown in yeast [20,30].